# bupivacaine hydrochloride

NDC: 71288-727
Generic name: bupivacaine hydrochloride
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, RETROBULBAR
Marketing started: 20231227
Marketing ended: 20260721
FDA application: ANDA216040

## Active ingredients

- BUPIVACAINE HYDROCHLORIDE: 7.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-727"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-727
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=daec9ee4-b666-485e-a153-4b5e5acc48a1